Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2007 | 1 |
2008 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome.
Dev Neurosci. 2011;33(5):414-27. doi: 10.1159/000330861. Epub 2011 Sep 2.
Dev Neurosci. 2011.
PMID: 21893967
Free PMC article.
Review.
Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test.
Costa AC, Scott-McKean JJ, Stasko MR.
Costa AC, et al.
Neuropsychopharmacology. 2008 Jun;33(7):1624-32. doi: 10.1038/sj.npp.1301535. Epub 2007 Aug 15.
Neuropsychopharmacology. 2008.
PMID: 17700645
Item in Clipboard
G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responses.
Costa AC, Stasko MR, Stoffel M, Scott-McKean JJ.
Costa AC, et al.
J Neurosci. 2005 Aug 24;25(34):7801-4. doi: 10.1523/JNEUROSCI.1699-05.2005.
J Neurosci. 2005.
PMID: 16120781
Free PMC article.
Item in Clipboard
Cite
Cite